Choosing Between Initial ART Options: Answering the Questions

In this episode, Marta Boffito, MD, PhD, FRCP, and Michelle Cespedes, MD, MS, discuss initial ART options, including:Recommended first-line ART options for most PWH according to DHHS, IAS-USA, EACS, BHIVA, and WHO guidelines Data for weight gain after ART initiation with different ARV classes and drugsWeight gain disparities by race and gender after ART initiationData from the RESPOND study including risk factors for weight gain and CV event risk with INSTI vs non-INSTI–based ART The impact of INSTIs on CV events in the Swiss HIV Cohort study Recommendations for ART and contraception for PWH of childbearing potential Drug–drug interactions between first-line ART and contraceptive options Guideline-recommended first-line ART options in pregnancy with a discussion of how these regimens differ from those recommended for most PWH Marta Boffito, MD, PhD, FRCP <br />Consultant Physician <br />Clinical Director, HIV, Sexual and Gender Health, Dermatology <br />Chelsea and Westminster Hospital NHS Foundation Trust <br />Imperial College London <br />London, United Kingdom Michelle Cespedes, MD, MS <br />Professor of Medicine <br />Division of Infectious Disease <br />Department of Medicine <br />Icahn School of Medicine at <br />Mount Sinai <br />New York, New York Link to full program: bit.ly/3HPu4Lk